Registered Nurse in Northlake, TX Accepting Medicare
5 Registered Nurse nurses found. Showing 1 - 5
 Margaret Stinnett, DNP, APRN, FNP-BC Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 4901 State Highway 114 Ste 102, Northlake, TX 76262 Phone: 214-986-8087 |
Rebecca Loving, RN, IBCLC Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 3313 Ironstone Rd, Northlake, TX 76226 Phone: 512-618-9422 |
Rosemary Christopher-long, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1528 Wolfberry Ln, Northlake, TX 76226 Phone: 469-855-5927 |
Kaley Leann Wymack, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 901 Meadows Dr, Northlake, TX 76226 Phone: 940-783-8633 |
Natasha Suzanne Smithey, RN, FNP-C Registered Nurse Medicare: Medicare Enrolled Practice Location: 1490 Commons Cir, Northlake, TX 76226 Phone: 940-400-0083 |
News Archive
Some vegetable oils claim to be healthy may actually increase heart disease risk
Some vegetable oils that claim to be healthy may actually increase the risk of heart disease, and Health Canada should reconsider cholesterol-lowering claims on food labelling, states an analysis in CMAJ (Canadian Medical Association Journal).
Amphetamine regimen does not improve post-stroke motor recovery
A pilot clinical trial exploring the benefit of d-amphetamine combined with physical therapy for stroke patients found no evidence that the regimen improved post-stroke motor recovery.
World No Tobacco Day observed worldwide
In a new online survey of 15,559 Internet users in China findings show that more than fifty percent smokers find it difficult to quit the habit without professional assistance. This survey came in the wake of the World No Tobacco Day observed on the 31st of May and supported by the media center of the Ministry of Health and the Life Times newspaper.
BDI Pharma's expanded portfolio boosts third-quarter revenue
BDI Pharma, Inc. (BDI), the fastest growing national distributor of biotech therapies, announced that revenue for the third quarter of 2009 continued to sustain the momentum experienced during the first two fiscal quarters of this year. A primary driver of third quarter revenue was the exceptional success of the company's expanded portfolio of specialty biotherapeutics.
› Verified 8 days ago